The first Italian biotech startup dedicated to researching, developing, and marketing bacteriophage-based therapies and derivatives to combat the global antibiotic resistance crisis.
Bacterial resistance to antibiotics is increasing worldwide, rendering conventional treatments ineffective. Our mission is to combat this antimicrobial resistance by harnessing the power of bacteriophages. We are dedicated to developing innovative phage-based technology that provide effective alternatives to traditional antibiotics.
Bacteriophages offer a promising alternative to traditional antibiotics. These naturally occurring viruses specifically target and destroy harmful bacteria without harming the beneficial microbiota, making them highly precise and efficient.
Read moreFagoterapia LAB is developing therapeutics based on bacteriophages, for the treatment of difficult infections and resistant bacteria of extreme clinical importance. We offer our expertise through different services.
Read moreA collection of potent, well-characterised phages.
Proprietary algorithms for the annotation and phage-host activity prediction.
Our experience in applying phage technology for clinical therapy.
Functional characterization of phage isolates.
Stay tuned for nice and crunchy news
News
Fagoterapia selected for Med4Cure
Fagoterapia will be part of IPCEI “Med4Cure”, the first important project of European interest in the health value chain.
2024-06-03
News
Aboutpharma: phage therapy
Phage therapy in Italy, between regulatory aspects and scientific developments
2023-02-13
News
First Italian patient cured with customised phage therapy
Fagoterapia LAB published the case report of the first patient successfully treated using customised phage therapy
2023-02-12
We are backed-up by top players
